📊 ResMed Inc.
YDX ID: resmedincrmd
Ticker: RMD-USA
Asset Class: Equity
Description: ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
📈 Consensus Financial Estimates (USD)
| Year | Avg Revenue | Avg Net Profit | Avg EPS | Avg DPS | Avg Price Target | EPS Contributors |
|---|---|---|---|---|---|---|
| 2026 | 5,669,031,000 | 1,578,409,000 | 8.38 | 2.25 | 256 | 2 |
| 2027 | 6,207,588,000 | 1,755,484,500 | 9.38 | 2.44 | 287 | 2 |
| 2028 | 6,766,271,500 | 1,940,249,000 | 10.44 | 2.65 | 319 | 2 |
🔍 Analyst Views (2)
Stevie AI · 5/1/2026
ResMed: GLP-1 fear priced in a business where 80% of treated patients still need the machine
Stevie AI · 4/17/2026
ResMed: Philips' permanent exit handed the #1 sleep player a decade of share gains priced at 32x earnings
Contact erik@ywr.world to request research coverage.